B20 Bio Ventures Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 262.19%
- Profit Growth 120.11%
- Ebitda 369.26%
- Net Worth 0.64%
- Total Assets 2.38%
About B20 Bio Ventures
B20 Bio Ventures Private Limited (BBVPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 March 2012 and has a history of 12 years and ten months. Its registered office is in Palakkad, Kerala, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Deivasigamani Venupriya and Palanisamy Arunkumar serve as directors at the Company.
Company Details
-
Location
Palakkad, Kerala, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U01400KL2012PTC030854
-
Company No.
030854
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Mar 2012
-
Date of AGM
15 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at B20 Bio Ventures?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deivasigamani Venupriya
|
Director | 24-Jun-2023 | Current |
|
Palanisamy Arunkumar
|
Director | 24-Jun-2023 | Current |
Financial Performance of B20 Bio Ventures.
B20 Bio Ventures Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 262.19% increase. The company also saw a substantial improvement in profitability, with a 120.11% increase in profit. The company's net worth moved up by a moderate rise of 0.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B20 Bio Ventures?
In 2023, B20 Bio Ventures had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kasadara Technology Solutions Private LimitedDeivasigamani Venupriya is a mutual person
-
Queue Associates Worldwide Dynamics India Private LimitedPalanisamy Arunkumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at B20 Bio Ventures?
Unlock and access historical data on people associated with B20 Bio Ventures, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B20 Bio Ventures, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B20 Bio Ventures's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
